News archive

October 2018

• • October 2, 2018
  • KBI Biopharma

  CytoSen Therapeutics and KBI Biopharma Enter into Strategic Partnership to Manufacture NK Cells and Nanoparticles

  Implementing scalable manufacturing processes to enable cGMP production of investigational Natural Killer cell therapies

September 2018

• • September 26, 2018
  • KBI Biopharma

  Selexis and Hoba Therapeutics Team Up to Advance Hoba’s Investigational Neuropathic Pain Treatment into the Clinic

  Selexis SUREtechnology Platform™ Successfully Expresses Hoba’s HB-086 in CHO Cells

• • September 26, 2018
  • Crown Bioscience

  CrownBio Completes Validation of Prostate Cancer Patient-Derived Xenograft (PDX) Models

  Unique well-characterized prostate models derived from castration resistant and hormone sensitive primary tissue now available for studies

• • September 18, 2018
  • Crown Bioscience

  CrownBio Licenses Translational Breast Cancer Models of Resistance and Metastasis

  CrownBio will market a set of new, highly characterized breast cancer models alongside their industry leading collection of more than 2500 PDX models (HuPrime®).

• • September 18, 2018
  • JSR Corporation

  Aspect Biosystems Announces Liver Tissue Collaboration with JSR

  Through this collaboration, Aspect’s proprietary Lab-on-a-Printer™ 3D bioprinting platform and JSR’s advanced materials technology will be used to develop vascularized human liver lobules.

• • September 10, 2018
  • Crown Bioscience

  CARsgen Therapeutics and CrownBio Complete CAR-T Study for Gastric Cancer

  Claudin18.2 specific CAR-T cells show tumor elimination in PDX models

• • September 4, 2018
  • KBI Biopharma

  KBI boosts analytical services with Belgium expansion - via BioProcess International

  KBI was featured in BioProcess International regarding the recent expansion to Belgium with KBI Biopharma BVBA.

August 2018

• • August 14, 2018
  • Crown Bioscience

  CrownBio Expands Genetically Engineered Model Selection Via Strategic Alliance with Shanghai Model Organisms Center (...

  Alliance enables researchers to access thousands of GEMMs

July 2018

• • July 27, 2018
  • Crown Bioscience

  CrownBio Expands Novel Humanized Models for Targeted Immunotherapy Development to San Diego, CA Research Center

  Humanized Model Expansion Program begins with PD-1, CTLA-4, and CD137 Models

• • July 19, 2018
  • Crown Bioscience

  CrownBio Supports Excellence in Translational Research with Grant Award that Funds Innovative PDX Model Development i...

  "Cancer Research Center of Lyon iPS novel PDX models formulate new immune cell focused strategies"

• • July 10, 2018

  Symphogen A/S and Selexis Expand Relationship as Symphogen Advances its Monoclonal Antibody (mAb) Mixture Pipeline

  Selexis SA today announced that under the terms of an earlier commercial license agreement, Symphogen A/S has opened two investigational new drug applications (INDs) for clinical programs utilizing...

June 2018

• • June 12, 2018
  • KBI Biopharma

  ProMIS Neurosciences Initiates Manufacturing of PMN310, its Lead Therapeutic Antibody for Treatment of Alzheimer’s Di...

  Program is on track for clinical trial start in H2 2019